- A recent survey carried out by a Washington-based trade association representing biotechnology companies found that 79% of 124 respondents have at least one contract or product agreement with a manufacturer based in China or owned by China.
BIO earlier this year had come out against the legislation and then later softened its stance, saying it wanted to work with legislators on the bills. WuXi AppTec, a China-based contract manufacturer whose business is largely from the United States, dropped out of BIO earlier this year.
Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen: